Research

OpenAI Researcher in Talks to Start AI Drug-Discovery Company

Source: TechCrunch AI Source published: 15 Jul 2026 NadiAI generated: 15 Jul 2026

Listen to Brief

AI audio in English, based on the NadiAI brief and original source.

Brief

Miles Wang, a researcher at OpenAI, is reported to be in funding discussions to launch an AI-driven drug discovery startup valued at about $2 billion. The talks suggest investor interest in using AI to accelerate breakthroughs in life sciences, according to TechCrunch AI.

Why It Matters

Significant funding interest could accelerate AI applications in drug discovery, potentially changing how new therapies are developed.

Keep Reading on NadiAI

Selected Related Articles